Papers by Keyword: Tissue Engineered Bone

Abstract: To develop a suitable scaffold for tissue-engineered bone regeneration, we compared the efficiency of tissue-engineered bone regeneration according to the porous structure of calcium metaphosphate (CMP) ceramic scaffolds. Each scaffold was prepared with a sponge method and a foam-gel method, respectively. Both scaffolds, having either interconnected trabecular pores formed by the sponge method or fully interconnected globular pores formed by the foam-based technology, were not cytotoxic and elicited neither an immune nor an inflammatory response regardless of geometry and fabrication method. The fully interconnected globular porous scaffold showed more favorable compression strength and facilitated osteogenic repair by favoring cellular attachment and osteogenic differentiation with good osteoconductivity compared to the interconnected trabecular pore structured scaffold. These results suggest that the fully interconnected globular porous structure would be more suitable for both a bone substitute and scaffold for bioactive material-based or cell-based tissue bone regeneration.

Abstract: Availability, storage and transportation of engineered bone tissue fabricated in vitro are major practical problems associated with adequate use of bone replacement grafts for the treatment of bone diseases. The ability to maintain viable engineered bone tissue would facilitate future clinical applications. In the present study, we investigated time required for transportation of engineered bone removed from cool storage, from the culture room to the operating room; and examined effects of cool storage on survival of engineered bone tissue. Bone marrowcells were obtained from the iliac bone of a 60-year-old male affected with lumbar spondylosis, and then incubated in standard medium. After two weeks in primary culture, cultured cells were trypsinized, and a concentrated cell suspension was incubated with a porous beta-TCP block. After 3 weeks of subculture with the osteogenic medium containing dexamethasone etc., engineered bone tissue was collected, stored for 0, 6, 12, 24 hours at 4 °C, and was subcutaneously implanted into the back of nude mice. Six weeks after implantation, implants were harvested. Before and after implantation, significant activity could be detected in all animals. In in vitro and in vivo situations, osteogenic activity of engineered bone tissue could be maintained even after 24 hours. These results provided information on appropriate storage conditions for engineered bone tissue.